Skip to main content
G

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Filings indexed 1,303 across all filing types
Latest filing 2024-10-23 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Extension of voluntary suspension 2 pages 110.3KB
Regulatory Filings
2024-10-23 English
Voluntary Suspension 2 pages 212.1KB
Regulatory Filings
2024-10-20 English
Trading Halt 2 pages 210.8KB
Regulatory Filings
2024-10-16 English
Update - Receipt of R&D Tax Incentive Refund 2 pages 104.8KB
Regulatory Filings
2024-10-07 English
Receipt of R&D Tax Incentive Refund 1 page 100.4KB
Regulatory Filings
2024-10-02 English
Investor webinar presentation 2 pages 114.6KB
Regulatory Filings
2024-10-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.